WEIGHT LOSS & PEPTIDES
Bremelanotide (PT-141) What it is used for FDA-approved bremelanotide medicine for acquired, generalized hypoactive sexual desire disorder in eligible premenopausal women. It is not approved for weight loss or male sexual performance.
COA
Form Subcutaneous injection
Product status FDA-approved product and dosage form reference
Availability Subject to clinical and pharmacy review
Patient pricing $88.00 per unit BEFORE TREATMENT
A clinical decision, Product selection, formulation and any prescription require an independent clinical evaluation. Catalog inclusion is not a recommendation or a guarantee of a prescription.
Your provider determines whether treatment is appropriate and explains any required monitoring and follow-up.
Reference: Official product information . Reviewed September 17, 2026. Approval is specific to this medicine and its labeled uses.
